Characterization of the GbpD-activated Rap1 Pathway Regulating Adhesion and Cell Polarity in Dictyostelium discoideum by Kortholt, Arjan et al.
  
 University of Groningen
Characterization of the GbpD-activated Rap1 Pathway Regulating Adhesion and Cell Polarity
in Dictyostelium discoideum
Kortholt, Arjan; Rehmann, Holger; Kae, Helmut; Bosgraaf, Leonard; Keizer-Gunnink, Ineke;
Weeks, Gerald; Wittinghofer, Alfred; Haastert, Peter J.M. van
Published in:
The Journal of Biological Chemistry
DOI:
10.1074/jbc.M600804200
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2006
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Kortholt, A., Rehmann, H., Kae, H., Bosgraaf, L., Keizer-Gunnink, I., Weeks, G., ... Haastert, P. J. M. V.
(2006). Characterization of the GbpD-activated Rap1 Pathway Regulating Adhesion and Cell Polarity in
Dictyostelium discoideum. The Journal of Biological Chemistry, 281(33), 23367 - 23376.
https://doi.org/10.1074/jbc.M600804200
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Characterization of the GbpD-activated Rap1 Pathway
Regulating Adhesion and Cell Polarity in
Dictyostelium discoideum*□S
Received for publication, January 26, 2006, and in revised form, May 24, 2006 Published, JBC Papers in Press, June 12, 2006, DOI 10.1074/jbc.M600804200
Arjan Kortholt‡, Holger Rehmann§, Helmut Kae¶, Leonard Bosgraaf‡, Ineke Keizer-Gunnink‡, Gerald Weeks¶1,
AlfredWittinghofer, and Peter J. M. Van Haastert‡2
From the ‡Department of Molecular Cell Biology, University of Groningen, Kerklaan 30, 9751 NNHaren, the Netherlands,
§Department of Physiological Chemistry and Centre of Biomedical Genetics, University Medical Center Utrecht, Universiteitsweg
100, 3584 CG Utrecht, The Netherlands, ¶Department of Microbiology and Immunology, University of British Columbia,
Vancouver, British Columbia V6T 1Z3, Canada , and Max-Planck-Institut fu¨r Molekulare Physiologie,
Otto-Hahn-Strasse 11, D-44227 Dortmund, Germany
The regulation of cell polarity plays an important role in che-
motaxis. GbpD, a putative nucleotide exchange factor for small
G-proteins of the Ras family, has been implicated in adhesion,
cell polarity, and chemotaxis in Dictyostelium. Cells overex-
pressing GbpD are flat, exhibit strongly increased cell-substrate
attachment, and extend many bifurcated and lateral pseudopo-
dia. These cells overexpressing GbpD are severely impaired in
chemotaxis, most likely due to the induction of many protru-
sions rather than an enhanced adhesion. TheGbpD-overexpres-
sion phenotype is similar to that of cells overexpressing Rap1.
Herewe demonstrate that GbpD activates Rap1 both in vivo and
in vitro but not any of the five other characterized Ras proteins.
In a screen for Rap1 effectors, we overexpressedGbpD in several
mutants defective in adhesion or cell polarity and identified
Phg2 as Rap1 effector necessary for adhesion, but not cell polar-
ity. Phg2, a serine/threonine-specific kinase, directly interacts
with Rap1 via its Ras association domain.
Rap proteins belong to the Ras superfamily of small GTPases.
Rap was first identified as an antagonist of Ras-induced trans-
formation and is capable of inhibiting multiple Ras signaling
pathways by binding to downstream targets of Ras (1, 2); how-
ever, Rap has since been shown to act in numerous Rap-medi-
ated signaling pathways. In mammalian cells Rap is involved in
processes like adhesion, exocytosis, differentiation, and cell
proliferation (3, 4).
Small GTPases act as molecular switches in numerous sig-
naling pathways. They switch between an activeGTP- and inac-
tive GDP-bound state. Ras activity is regulated by guanine
nucleotide exchange factors (GEFs)3 that catalyze the exchange
of GDP for GTP, thereby activating the Ras protein. The inac-
tivation is catalyzed by GTPase-activating proteins (GAPs),
which accelerate the intrinsic slow GTP hydrolysis by many
orders of magnitude (5).
In the social amoebaeDictyosteliumdiscoideumRas proteins
are involved in a wide variety of processes, including cell move-
ment, polarity, cytokinesis, chemotaxis, macropinocytosis, and
multicellular development (6–8). During the vegetative state,
Dictyostelium are single-celled amoebae that feed on bacteria.
Upon starvation, cells undergo a tightly regulated developmen-
tal process in which they secrete and chemotax toward cAMP,
resulting in multicellular fruiting bodies.
Recently the assembly of the Dictyostelium genome was
completed (9), and 25 sequences encoding putative Ras-GEFs
were identified (10), 5 of which have been characterized to
some extent. RasGEFA, formerly referred to as AleA, and Ras-
GEFfM have a role in chemotaxis, and RasGEFB is involved in
endocytosis (11–13). Two proteins, GbpC and GbpD (also
referred to as RasGEFT and RasGEFU, respectively), that were
identified in a screen for cGMP binding domains also contain
CDC25 homology domains (14). GbpC belongs to the family of
ROC GTPases and has a unique domain architecture: it con-
tains a GTPase domain, a kinase domain, a CDC25-homology
domain, a Ras exchange motif (REM) domain, a GRAM
domain, and two cyclic nucleotide binding (cNB) domains (15).
Mutant studies showed that GbpC is the high affinity cGMP-
binding protein involved in regulation of myosin II (16). GbpD
is homologous to theC-terminal half ofGbpC and also contains
a CDC25 homology domain, GRAM, and two cyclic nucleotide
binding domains. Contrary to gbpC-nullmutants, which showa
strongly reduced chemotaxis, gbpD-null mutants display
improved chemotaxis and appear hyperpolar because cells
make very few lateral pseudopodia while still retaining the abil-
ity to remodel the leading edge. Overexpression of GbpD
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results in severely reduced chemotaxis as these cells extend
many bifurcated and lateral pseudopodia, resulting in the
absence of a leading edge. Furthermore, GbpD-overexpressing
cells (GbpDOE) are flat and adhesive due to an increased num-
ber of substrate-attached pseudopodia (17). In mutant cells,
which have no detectable cAMP and cGMP, overexpression of
GbpD still induces strong adhesion and loss of cell polarity,
suggesting that the activity of GbpD is not dependent on intra-
cellular cGMP or cAMP. In support of these data, radioactive
cyclic nucleotide binding assays revealed no detectable binding
of cAMP or cGMP to GbpD (16). The flattened morphology
and increased adhesion of the GbpD-overexpressing cells is
similar to that of cells overexpressing Rap1, suggesting that
both proteins function in the same pathway (18). In this paper
we show by in vivo pulldown assays and in vitro nucleotide
exchange measurements that GbpD is a Rap-specific GEF
involved in substrate attachment and cell polarity. So far, the
Rap signaling pathway has not been characterized inDictyoste-
lium. To identify downstream targets of GbpD/Rap in Dictyos-
telium, GbpD was overexpressed in null mutants of genes
involved in adhesion or cell polarity. Using this assay, Phg2 was
identified as a Rap1 effector, essential for regulation of sub-
strate attachment but not for cell polarity. Phg2 is a serine/
threonine-specific kinase, previously identified in a screen for
mutants defective in phagocytosis, that plays a role in phagocy-
tosis, cellular adhesion, actin cytoskeleton organization, and
motility (19). Beside the kinase domain, Phg2 contains proline-
rich repeats and a Ras association (RA)/Ras binding domain
(RBD) (19). Using guanine nucleotide dissociation inhibition
(GDI) measurements, we demonstrated a direct binding of
Rap1 to the RA domain of Phg2. These results suggest that
GbpD and Rap1 are upstream activators of Phg2 in cell adhe-
sion. Although phg2-null mutants overexpressingGbpD lacked
the strong cell-substratum attachment, they still displayed
defects in chemotaxis, indicating that the involvement of GbpD
in cell polarity is important for chemotaxis ofmigratingDictyo-
stelium cells.
EXPERIMENTAL PROCEDURES
Cell Culture—AX3 (wild-type), DH1 (a uracil auxotroph
wild type, kindly provided by Dr. Cosson), and the indicated
mutant cell lines were grown in HG5 medium (14.3 g/liter
peptone, 7.15 g/liter glucose, 0.49 g/liter KH2PO4, and 1.36
g/liter Na2HPO4H2O) to a density of no more than 2  106
cells/ml. Depending on the antibiotic resistance cassette pres-
ent in the plasmids, the medium was supplemented with 10
g/ml G418 (Invitrogen), 10 g/ml Blasticidin S (ICN), and/or
10 g/ml hygromycin B (Invitrogen). Rap1S17N cells were
grown in the presence or absence of 10 g/ml tetracycline
(Roche Applied Science). The phg2-, talinA-, and myosin VII-
null cell lines were kindly provided by Dr. Cosson (19).
Construction of Plasmids—For expression of GbpD in Dic-
tyostelium, the previously described MB74 GbpD vector was
used (17). For the regulated expression of Rap1S17N, the pre-
viously described tetracycline-controlled inducible expression
system was used (20). The Rap1 mutant was amplified from




quently, the BamHI-SphI fragment was cloned into the
BglII-SphI of the response plasmid MB38 (20). Five g of
plasmid DNA was transfected in tet7 cells, which already
contain the transactivator plasmid MB35 (20). For expres-
sion and purification of the GEF domain of GbpD (amino
acids 1–587), Phg2RA (amino acids 583–680), full-length
RasG and the C-terminal-truncated RasC (amino acids
1–170), and Rap1 (amino acids 1–169) proteins, the encod-
ing DNA fragments were cloned in pGEX-4T3 (GE Health-
care) leading to the corresponding N-terminal GST fusion
proteins. The GEF domain was amplified using the forward
primer (5-TGGATCCGAAAAAATGACAGATTACCCA-
TTC-3) and the reverse primer (5-GTTATCTAGACTGC-
AGTGATGATGTCTCTTCTCTAATC-3) with MB74 GbpD
as the template. The DNA fragment was subcloned in pGEM-
T-Easy (Promega) and sequenced. Subsequently, the GbpD
fragment was released and cloned into the BamHI and NotI
sites of pGEX-4T3 (GE Healthcare). The RA domain of Phg2
was amplified from cDNA with the forward primer (5-
GGATCCATGGTTCAACCAAAAGATATTATG-3) and
reverse primer (5-GAGCGGCCGCTTATTGTTGTTTATG-
TGTGAC-3). The RasG gene was amplified from cDNA using
the forward primer (5- GAGGATCCATGACAGAATACAA-
ATTAG-3) and reverse primer (5-CAGCGGCCGCTTATA-
AAAGAGTACAAGC- 3). The C-terminal-truncated RasC
was amplified from cDNA using the primers 5-GGATCCAT-
GTCAAAATTATTAAAATTAG-3 and 5-GAGCGGCCGC-
TTATCTTTTAATTTCTCTAACG-3. The C-terminal-trun-
cated Rap1 was amplified using the forward primer (5-
GGATCCAAAATGCCTCTTAGAGAATTC-3) and reverse
primer (5-GAGCGGCCGCTTAACGGTTGATTTGAC-
GGATTAAG-3) with genomic DNA as the template. The
fragments were digested with BamHI and NotI and cloned
in pGEX4T-3. The expression vectors were checked by
sequencing.
Protein Preparation—The GST fusion constructs were
expressed in BL21(DE3)codonplus-RIL cells (Stratagene). The
cells were grown in Standard I medium (Merck) containing 50
g/ml ampicillin and 25g/ml chloramphenicol, induced at an
A600 of 0.8 with 0.1 mM isopropyl-1-thio--D-galactopyrano-
side and incubated overnight at 25 °C. After protein produc-
tion, the cells were pelleted (15 min, 4000 g, 4 °C), washed in
0.9% NaCl, and resuspended in lysis buffer (5 mM 1,4-dithio-
erythritol, 50 mMNaCl, 5 mMMgCl2, 30 mMTris-HCl, pH 7.9).
To inhibit protein degradation, 1mMphenylmethylsulfonyl flu-
oride was added. Cells were lysed in amicrofluidizer (Microflu-
idizer Inc.), and 0.1 mg/ml DNase I was added. Lysates were
cleared by centrifugation (45 min, 100,000  g at 4 °C), and
fusion proteins were purified using a glutathione-Sepharose
(GSH) affinity column (GE Healthcare). RasG and the C-trun-
cated RasC and Rap1 proteins were eluted from the column as
GST fusion proteins in lysis buffer containing 20 mM glutathi-
one. For GbpDGEF, the GST tag was cleaved on the column
using 200 units of thrombin (SERVA) followed by elution of the
protein in lysis buffer. Isolated proteins were analyzed using
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SDS-PAGE, and the protein concentration was determined
using the Bradford method (Bio-Rad).
Guanine Nucleotide Exchange Assays—For the in vitromeas-
urement ofGEF activity, theGTP-binding proteinswere loaded
with the fluorescent GDP analoguemGDP by incubation in the
presence of 10mM EDTA and a 20-fold excess of mGDP for 2 h
at room temperature (21). The mGDP-loaded GTPases were
incubated at 25 °C in assay buffer (50 mM Tris-HCL, pH 7.5, 5
mM MgCl2, 50 mM NaCl, and 5 mM 1,4-dithioerythritol) con-
taining a 200-fold excess of unlabeled GDP, with the indicated
amounts of GEF protein. The nucleotide exchange activity was
measured in real time as decay in fluorescence using a Spex1
spectrofluorometer (Spex Industries), with excitation and
emission wavelength of 366 and 450 nm, respectively. The
obtained datawere fitted to a single exponential decay using the
program Grafit (Erithacus software).
GDI Measurements (Assay)—For the GDI measurements,
Rap1 was loaded with mGppNHp by incubating in ammonium
sulfate buffer (200 mM (NH4)2SO4, 50 mM 1,4-dithioerythritol,
10 M ZnCl2, pH 7.6) containing alkaline phosphatase (2
units/mg Rap1 protein) and a 1.5 M excess of the fluorescence
GTP analogue mGppNHp (22). The protein-nucleotide com-
plex was separated from unbound nucleotides by size exclusion
chromatography (Superdex 75 16/20, GE Healthcare).
The affinity between Phg2-RA and Rap1 was determined
using the inhibition of the mGppNHp release from Rap1 as
described (23). Shortly, 200 nM mGppNHp-loaded Rap1 in the
presence of varying concentrations of Phg2-RA and a 200-fold
excess of unlabeled GppNHp was incubated in assay buffer at
25 °C. The decay in fluorescencewasmeasured in a Spex1 spec-
trofluorometer (Spex Industries), with excitation and emission
wavelengths of 366 and 450 nm, respectively. The observed rate
constants (kobs) were single exponential-fitted using the pro-
gram Grafit (Erithacus software). The dependence of the
observed rate constants on the effector concentrationwas fitted
to yield the dissociation constant (Kd) as described (23).
RBD Pulldown Assay—The assay was performed as described
previously (24). In brief, cellswere grownby shaking inHL5media
supplemented with 50 g/ml streptomycin (Sigma), resuspended
at 5 107 cells/ml in KK2 (20 mM potassium phosphate, pH 6.1),
and lysed aftermixingwith an equal volumeof 2HK-LB (20mM
sodiumphosphate,pH7.2, 2%TritonX-100, 20%glycerol, 300mM
NaCl, 20 mM MgCl2, 2 mM EDTA, 2 mM Na3VO4, 10 mM NaF,
with two tablets of protease inhibitors (Roche Applied Science
Complete) added per 50 ml of buffer). Lysates were incubated on
ice for 5 min and cleared by centrifugation for 10 min. Protein
concentrations were determined using theDCprotein assay (Bio-
Rad). Dictyostelium lysates (800 g of protein) were incubated
with100gofGST-RBDprotein coupled toGSHbeads at 4 °C for
1 h. Beadswere harvested by centrifugation andwashed 3 times in
1HK-LB. 40l of 1 SDS gel loading buffer (0.5%-mercapto-
ethanol, 0.5% SDS, 50 mM Tris-HCl pH 6.8, 12.5% glycerol, and
0.04% bromphenol blue) was added to the pelleted beads, and the
mixture was boiled for 5 min. Samples were fractionated by SDS-
PAGE, blotted onto nitrocellulose, blocked with nonfat milk, and
probedwith either RasC (25) or RasG (26) antibody. The amounts
of boundRasC andRasGwere determined by anECL (Amersham
Biosciences) reaction.
Adhesion Assay—Toquantify cell adhesion to the surface, we
used a previously published protocol (27) with a few modifica-
tions. Briefly, cells were grown in HG-5 medium on 6-well
plates (Nunc) to a maximum of 70% confluence. The medium
was replaced and incubated for 1 h. Then, plates were rotated
on a rotary shaker at 150 rpm, and after 1 h a sample of 150l of
the medium was taken. The remaining medium was removed
and replenished with fresh HG-5, and the remaining adhering
cells were detached by repeated pipetting. The number of cells
in the two samples was determined in triplicate using a hemo-
cytometer. The amount of loose cells in the first sample was
divided by the total number of cells (first plus second sample) to
yield the percentage of loose cells.
Chemotaxis Assay—Chemotaxis toward cAMP was tested
using micropipettes filled with 104 M cAMP applied to a field
of aggregation competent cells with an Eppendorf femtotip at a
pressure of 25 hectopascals. Cells were starved in 10 mM phos-
phate buffer, pH 6.5 (PB) for 6–8 h, resuspended in PB, and
monitored by phase contrast microscopy. The motile behavior
of cells in spatial gradients of cAMP was analyzed using com-
puter-assisted methods previously described (28). Briefly,
images were recorded every 10 s for a period of 15 min. The
contour of the cells and position of the cell centroids were
determined at 1-min intervals for DH1 and phg2 and at 3-min
intervals for DH1/GbpDOE and phg2/GbpDOE.
RESULTS
GbpD Is a Guanine Nucleotide Exchange Factor for Rap1—
GbpD contains a CDC25 homology domain and a REM and is,
therefore, predicted to possess guanine nucleotide exchange
activity on members of the Ras subfamily of GTPases (14).
Fourteen Ras subfamily proteins have been identified in the
Dictyostelium genome, an unusually large number (7). Thus far,
six Ras subfamily members have been characterized, and they
all appear to have important roles in cell physiology (6–8, 10).
RasC and RasG are the best characterized Dictyostelium Ras
proteins, and both are activated in response to cAMP (24).
RasG regulates cell motility and the cytoskeleton during vege-
tative state (29), and both RasC and RasG are involved in regu-
lation of the cAMP relay and cAMP-dependent chemotaxis
(25).4 RasB is linked to the progression through the cell cycle
(30), and RasD is involved in both phototaxis and thermotaxis
(31), whereas RasS is involved in endocytosis and the regulation
of cell motility (32). The only thus far characterized Rap sub-
familymember, Rap1, is essential inDictyostelium and involved
in proliferation, growth, adhesion, and regulation of the
cytoskeleton (18, 33, 34).
To characterize the specificity of GbpD, we determined
GDP/GTP exchange activity on the six characterized Ras sub-
family members using in vitro fluorescence exchange measure-
ments. For these experiments, the catalytic GEF domain of
GbpD was expressed in Escherichia coli and isolated as a
66-kDa protein (data not shown). The Ras proteins (RasB, -C,
-D, -G, and -S) and Rap1 were isolated from E. coli as C-termi-
nal-truncated proteins. C-terminal-truncated Ras proteins
possess the same biochemical and structural properties as the
4 P. Bolourani, unpublished observation.
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full-length protein but are much more stable than the full-
length proteins (22). The Ras and Rap proteins were loaded
with the fluorescentGDP analoguemGDP and incubated in the
presence of excess GDP. Nucleotide exchange wasmeasured in
real time as a decay in fluorescence, caused by the release of
mGDP, which shows a higher fluorescence intensity when
bound in the hydrophobic environment of Rap than in the
buffer solution. To control for the stability and folding of the puri-
fied Dictyostelium Ras and Rap proteins, the human Ras-specific
GEF CDC25 and the highly active Rap-specific GEF C3G were
used as controls. As expected, the GDP exchange activity of Dic-
tyostelium Rap1 was enhanced by C3G, but not by CDC25, and
exchange activity of RasC and RasGwas enhanced by CDC25 but
not by C3G (Fig. 1), indicating that the purified proteins are stable
and functional. The slower decay of fluorescence of RasC com-
pared with RasG may be due to the lower degree of homology to
human Ras that RasC exhibits and, thus, is less sensitive to activa-
tion by human CDC25 (6). The addition of GbpDGEF tomGDP-
loaded Rap1 resulted in a rapid decrease in fluorescence and,
hence, acceleration of mGDP exchange (Fig. 1A). Fig. 1, B and C,
show that the addition of GbpDGEF to mGDP-loaded RasG and
RasC did not result in a decrease in fluorescence. GbpD was also
unable to accelerate nucleotide exchange on RasB, RasD, or RasS,
which were activated by human CDC25 (supplemental data).
These results suggest thatGbpDspecifically activatesRap1 in vitro
and not RasB, -C, -D, -G, and -S.
It was previously shown that the RBD of human RalGDS can
be effectively used to detect the amount of activated Dictyoste-
lium Rap1 in vivo (33). Kae et al. (24) described a similar
method in which they used the RBD of Schizosaccharomyces
pombe Byr2 to detect the amount of GTP loaded RasC and
RasG (24). To further determine the activity and specificity of
GbpD, the amount of activated Ras proteins in wild type AX3
cells, in gbpD-null cells, and in GbpDOE cells was determined.
The amount of Rap1-GTP is significantly higher in GbpDOE
mutant cells than in wild type and gbpD-null cells, whereas the
total amount of Rap1 is similar in all three cell lines (Fig. 2).
Seastone et al. (34) have previously shown that modest overex-
pression of Rap1 results already in the described strong pheno-
type. These data support the in vitro data and suggest that
GbpD acts as a RapGEF in vivo.
FIGURE 1. Activation of Ras proteins by GbpD in vitro. GEF activity was measured with excess GDP under standard conditions using 200 nM mGDP-
loaded Rap1 (A), mGDP-loaded RasG (B), or mGDP-loaded RasC (C) in the absence (open triangle) or presence of 100 nM GbpD (closed circle), the
RapGEF-specific C3G (open circle), and RasGEF-specific CDC25 (closed triangle). The nucleotide exchange was measured in real time as decay in
fluorescence, as indicated in under “Experimental Procedures.” Experiments with mGDP-loaded RasS, RasD, and RasB yielded similar results as for RasG
and are shown as supplemental data.
FIGURE2.Activationof Ras proteins byGbpD in vivo. The RBDs of RalGDS
(for Rap1) or Byr2 (for RasC and RasG) were used to detect the amount of
active Ras protein in lysates of AX3, gbpD-null, and GbpDOE cells. Lysates
were incubated for 1 h at 4 °C with 100 g of GSH bead-bound GST-RBD,
and the beads were pelleted by centrifugation. The amount of Ras protein
in the pulldown fraction or lysate was detected by Western blot analysis,
determined using specific antibodies against Rap1, RasC, and RasG. The
experiment is representative for three separate experiments.
GbpD-activated Rap Pathway
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The GST-Byr2 pulldowns, analyzed by Western blotting
using antibodies against RasC and RasG, showed similar
amounts of activated RasG in all 3 cell lines, but reproducibly,
an increased amount of GTP-RasC was detected in GbpDOE
cells (Fig. 2). Because GbpD is not able to activate RasC in vitro,
the increased activation of RasC seen in vivomay be due to an
indirect effect.
Rap1 Mediates GbpD-induced Adhesion and Pseudopodia
Formation—The pulldown assays revealed that Rap1 and pos-
sibly RasC are potential targets of GbpD in vivo. To investigate
the possible role of RasC in the GbpDOE phenotype, we overex-
pressed GbpD in rasC-null cells. The rasC/GbpDOE mutant
possessed the characteristic GbpDOE phenotype, a strong
increased attachment to the substratum (Fig. 3C) and a very flat
cell morphology (Fig. 3A), indicat-
ing that RasC is not essential for
mediating the effect of GbpD.
To investigate if Rap1 indeed
mediates the GbpD-induced adhe-
sion and pseudopodia formation,
GbpD was expressed in cells
expressing dominant negative Rap1
(Rap1S17N). The Rap1-S17N sub-
stitution restricts the protein to the
GDP-bound state and interferes
with the endogenous Rap protein
(18). RapS17N cells have altered
phagocytosis, adhesion, polarity,
and viability (18, 20, 33, 34, 35).
Because of this strong phenotype,
we decided to tightly control the
expression of Rap1S17N using the
previously described tetracycline-
controlled inducible expression sys-
tem (20). Briefly, this system
employs a promotor by which the
expression of the downstream gene
is negatively regulated by tetracy-
cline. Rap1S17N/GbpDOE mutants
grown in the presence of tetracy-
cline (Rap1S17N off) possessed
the characteristic GbpDOE pheno-
type, a strong increased attach-
ment to the substratum (Fig. 3C),
and a very flat cell morphology
(Fig. 3B). Rap1S17N/GbpDOE cells
grown in the absence of tetracy-
cline (Rap1S17N on) lack both the
alteration in morphology as well as
in adhesion. These data support
our conclusion that GbpD is a
Rap-GEF, mediating adhesion and
pseudopodia formation.
Phg2 Mediates GbpD-induced
Adhesion but Not Pseudopodia
Formation—The strong GbpDOE
phenotype provides a powerful tool
to screen for downstream targets of
GbpD and Rap1 in Dictyostelium. GbpD was overexpressed in
mutants with deletions in genes known to be involved in cell
adhesion, talinA,myosinVII, and phg2. TalinA is an actin-bind-
ing protein necessary for phagocytosis and adhesion (36), myo-
sin VII is involved in both cell-cell and cell-substrate adhesion
(36), and Phg2 plays a role in the modeling of actin-rich focal
sites and in cell motility (19, 37). First, the morphology of the
mutants was analyzed microscopically. Wild type (DH1, top)
and DH1/GbpDOE (bottom) cells are shown in the left panel of
Fig. 4A. TheGbpDOEmutants extendedmore pseudopodia and
were flat and large compared with the parent cell lines, and a
similar phenotypewas obtainedwhenGbpDwas overexpressed
in phg2-, talinA-, or myosin VII-null. However, although
starved phg2-, talinA-, andmyosin VII-null cells aggregate and
FIGURE3.CellmorphologyandadhesionofRasCandRap1mutantsoverexpressingGbpD. To investigate
the role of RasC and Rap1 in the GbpD pathway, GbpD was expressed in DH1, rasC, and Rap1S17N cells.
Rap1S17N expression was controlled using a tetracycline-regulated expression system. In cells grown in the
presence of tetracycline, expression of Rap1S17N is inhibited (off), whereas in the absence of tetracycline
expression of Rap1S17N is promoted (on). RasC mutant (A) and Rap1 mutant (B) cell lines were analyzed
microscopically. Imageswere obtained from cells growing in HG-5medium. C, cell attachmentwas studied for
the indicated mutants. Vegetative cells were shaken at 150 rpm in HG5 medium. After 1 h a sample of the
medium was taken, and the remaining cells were detached. The number of cells in both samples was deter-
mined in triplicate using a heamocytometer and used to calculate the percentage of loose cells. The results
show the means and S.D. of three independent experiments.
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develop morphologically normal, GbpDOE cells were unable to
aggregate (data not shown). These data indicate that Phg2,
talinA, and myosin VII are not essential downstream compo-
nents of GbpD for its role in cell morphology (Fig. 4A).
A second characteristic of the strain overexpressing GbpD is
its strong attachment to the substratum;mutants lackingGbpD
are less adherent to the substratum than wild type cells. There-
fore, the adhesive capacities of the mutants were tested via an
adhesion assay. As shown in Fig. 4B, 65% of the DH1 cells
were detached after shaking compared with only 18% for the
DH1-overexpressing GbpD. These values are slightly higher
than those published previously, whichmay reflect the different
parental cell line used in these experiments and the use ofHG-5
instead of phosphate buffer (17). In the mutants lacking talinA,
myosin VII, or phg2, the percentage of loose cells after 1 h of
shaking was about 70%, slightly higher than that of wild type.
These defects in adhesion are smaller than those published
before, whichmay reflect the differentmethod used and the use
of Nunc plates instead of glass (19). Overexpressing GbpD in
cells deficient of myosin VII or
talinA resulted in a strong increase
in cell attachment (Fig. 4B), similar
to that observed with the overex-
pression of GbpD in wild type cells.
In contrast, overexpression of
GbpD in phg2-null cells had no
effect on cell attachment (Fig. 4B).
These data suggest Phg2 is a down-
stream component of the GbpD
pathway, essential for its role in
adhesion.
Phg2 Interacts Directly with Rap1
via Its RA Domain—Phg2 is a ser-
ine/threonine-specific kinase in-
volved in phagocytosis, adhesion,
and organization of the actin
cytoskeleton (19). In addition to a
kinase domain, the protein contains
two proline-rich domains, through
which itmay interact with other cel-
lular proteins, and aRAorRBD (19).
RA/Ras binding domains have an
ubiquitin fold and interact tightly
only with GTP bound and not
GDP-bound Ras-like proteins
(38). Gebbie et al. (19) used yeast
two-hybrid analysis to character-
ize the interaction between
Phg2-RA and three members of
the Dictyostelium Ras family,
RasG, RasS, and Rap1. They
showed that Phg2-RA is able to bind
all three GTPases but preferentially
binds Rap1 (19). To quantify the
ability of Rap1 to bind directly to
Phg2-RA, we performed a GDI
assay (23). The interaction of an
effector with the GTP-bound
G-protein stabilizes the interaction between the G-protein
and the nucleotide. This stabilization results in decreased
dissociation of the nucleotide from the G-protein-nucleo-
tide-effector complex. Incubating Rap1 loaded with mGp-
pNHp, a hydrolysis-resistant fluorescent GTP analogue,
with an excess of unlabeled GppNHp results in the exchange
of mGppNHp for GppNHp. This exchange can be monitored
as a decay in fluorescence, and the resulting kobs is a measure
of effector binding. Adding increasing concentrations of the
effector results in a concentration-dependent decrease of
kobs (Fig. 5A). The affinity between Rap1 and the effector
(Kd) can be determined from this dependence (23). For the
interaction of Rap1 with the RA domain of Phg2, we deter-
mined a Kd of 30 M (Fig. 5B). From this data we conclude
that Phg2 is able to interact with Rap-GTP via its RA domain.
We also investigated the GDI effect of Phg2-RA of RasC and
observed no inhibition on nucleotide exchange, suggesting
the absence of an interaction between RasC and Phg2-RA
in vitro (data not shown).
FIGURE 4. Cell adhesion of Dictyostelium mutants overexpressing GbpD. A, to screen for downstream
targets of GbpD, GbpD was expressed in DH1, talinA-,myosin VII-, and phg2-null. Parent and mutant cell lines
were analyzed microscopically. Images were obtained from cells growing in HG-5 medium. The GbpDOE
mutants extendmuchmore pseudopodia and are very flat comparedwith the parental cell lines. B, cell attach-
mentwas studied for the indicated nullmutantswith andwithout overexpression of GbpD, as described in the
legend to Fig. 3B.
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GbpD/Rap-regulated Cell Morphology Is Important for
Proper Chemotaxis in Dictyostelium—GbpDOE cells are char-
acterized by an increased attachment to the substratum and
increased numbers of pseudopodia, resulting in a severe defect
in chemotaxis. Expression of GbpD in phg2-null cells also
resulted in an increased amount of pseudopodia but did not
result in an increased attachment to
the substratum, nor in HG-5
medium (see Fig. 4) or 10 mM phos-
phate buffer, pH 6.5 (data not
shown). Therefore phg2/GbpDOE
cells provide a tool to discriminate
between the effects of GbpD on the
adhesion versus the cell polarity
components for chemotaxis. DH1,
DH1/GbpDOE, phg2, and phg2/
GbpDOE cells were starved for sev-
eral hours, and chemotaxis toward
cAMP was measured. In GbpDOE
cells developed for similar periods
of time it previously has been shown
that the cAMP-stimulated accumu-
lation of filamentous actin was
essentially normal, indicating that
the cells develop a competent signal
transduction pathway (17). When a
pipette filled with cAMP is placed in
the surrounding of wild-type cells,
cells rapidly respond and chemotax
persistently toward the source of
cAMP, as depicted in Fig. 6. Cells
lacking Phg2, although moving
slower, exhibit a chemotaxis response
that is essentially identical to the
response of wild type cells (Fig. 6,
lower left panel). Overexpression of
GbpD in wild type cells or in phg2
null cells negatively affects chemo-
taxis as these cells showed littlemove-
ment toward the pipette. These
results suggest that the chemotaxis
defect of GbpDOE cells is not due to
the increasedcell adhesion to the sub-
stratebutmore likelydue todefects in
maintaining proper cell polarity.
DISCUSSION
Dictyostelium GbpD was previ-
ously characterized as a CDC25-ho-
mology domain-containing protein
involved in cell attachment and cell
polarity (17). In this study the func-
tion of GbpD was explored in more
detail. First the specificity of the
guanine nucleotide exchange activ-
ity was tested by in vivo pulldown
and in vitro fluorescence exchange
assays. Both experiments showed
activity of GbpD on Dictyostelium Rap1, whereas no exchange
activity was detected for RasB, -C, -D, -G, and -S. In vivo (as
measured by a Byr2-RBD pulldown assay) an increase of both
Rap1-GTP and RasC-GTP levels was observedwhenGbpDwas
overexpressed. However, becauseGbpDdoes not activate RasC
in vitro, we suspect the effect on RasC to be indirect, Further-
FIGURE 5. Interactionbetween theRAdomainof Phg2andRap1.A, the dissociation rate ofmGppNHp from
Rap1 was measured in the presence of varying concentrations of Phg2-RA and are presented for 90 M (open
circle), 70 M (closed circle), 50 M (open triangle), 20 M (closed squares), 10 M (closed triangles), and 0.1 M
(open squares) of Phg2-RA. These data were used to calculate the observed rate constants, kobs. B, the Kobs
values were plotted against the indicated effector concentrations of Phg2-RA. The addition of increasing
concentrations of the effector results in a concentration-dependent decrease of kobs. These data were used to
calculate the dissociation constant of the Rap1GTP-Phg2RA complex yielding a Kd of 30 M.
FIGURE 6. Chemotaxis assay. To analyze the chemotaxis behavior of DH1, phg2, DH1/GbpDOE, and phg2/
GbpDOE strains, cells were starved for 6–8 h, resuspended in 10 mM phosphate buffer, pH 6.5, and monitored
by phase contrast microscopy. Cells were stimulated at the right side with a micropipette containing 104
cAMP. The figures show the contour of the cell at 1-min interval for DH1 and phg2 and at 3-min intervals for
DH1/GbpDOE and phg2/GbpDOE for 15 min.
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more, a rasC/GbpDOE cell line still possesses the characteris-
tic GbpDOE phenotype, indicating that RasC is not an essential
component downstream of the GbpD signaling pathway. The
RapS17N/GbpDOE cell line does not have the GbpDOE pheno-
type, confirming our conclusion thatDictyosteliumGbpD pos-
sesses an active GEF that is specific for Rap1.
The mechanism of regulation of GbpD remains unclear.
Although GbpD contains two cyclic nucleotide binding
domains, so far no binding of cAMPor cGMP toGbpDcould be
detected (16). Additionally, the strong GbpDOE phenotype is
independent of the presence of cAMP/cGMP, indicating that
the activity of GbpD is at least not strictly regulated by cyclic
nucleotides (17). Mammalian PDZ-GEF1 and -2, which also
contain a CDC25-homology domain and a cyclic nucleotide
binding (cNB) domain, also seem to function without cAMP or
cGMP (39). Interestingly, like GbpD, PDZ-GEF is a Rap-spe-
cific GEF (39, 40).
Cells overexpressing Rap1 are flat, extend many substrate-
attached pseudopodia, and are highly adhesive (18, 35), pheno-
types strikingly similar to that of the GbpDOEmutant. Multiple
attempts to generate a rapA-null cell line failed and antisense
rapAmRNA resulted in cells with defects in growth and viabil-
ity, suggesting an essential role for Rap1 in Dictyostelium
(33).Because, a disruption in gbpD is not lethal and gbpD-null
cells still contain active Rap (Fig. 2), there must be at least one
other GEF for Rap1.
So far no GEFs, GAPs or downstream targets of Rap1 have
been identified in Dictyostelium. Mammalian Rap, like Dic-
tyostelium Rap1, participates in processes such as phagocy-
tosis, adhesion, and chemotaxis (3). Mammalian Rap is
involved in adhesion by regulating integrins, cadherins, and
actin dynamics, but whereas the direct downstream effectors
mediating these effects have not been unequivocally identi-
fied (4), several proteins that interact with activated mam-
malian Rap have been described. The effector protein RapL,
which consists of a RA domain and a coiled-coil domain, is
involved in Rap1-induced integrin-mediated cell adhesion
(41). Riam is a protein involved in Rap1-mediated actin
dynamics, probably by binding to profilin and Ena/Vasp and
needs both its RA and PH domain for interaction with Rap
(42). Binding of Rap to Arap3, which contains both an ARF-
GAP and a RhoGAP domain, might mediate down-regula-
tion of RhoA and subsequently affect regulation of actin
dynamics (43). In addition, Rap1 directly interacts with the
DH-PH domain of the RacGEFs Vav2 and Tiam1, regulating
their translocation to cell protrusions (44). As an indication
of the complexity of the Rap signaling pathway, the well
characterized Ras effectors Raf1 and B-Raf have also been
described as putative Rap effectors, suggesting that the there
is a level of cross-talk between the Rap and Ras pathways
(45). The Dictyostelium Rap pathway is involved in regula-
tion of similar processes, and because of its genetic tracta-
bility, Dictyostelium presents a good model for characteriz-
ing the basic interactions of Rap-regulated pathways.
To identify downstream targets of Rap1 in Dictyostelium,
GbpD was overexpressed in cells ablated for proteins previ-
ously shown to be involved in adhesion. In this way we were
able to identify Phg2 as an essential downstream component
of GbpD-mediated adhesion. Like many of the mammalian
Rap effectors, Phg2 contains a putative RA domain. Using
the yeast two hybrid system Gebbie et al. (19) showed that
the Phg2-RA domain is capable of interacting with members
of the Ras family and preferentially binds to Rap1 (19). We
measured the Phg2-RA/Rap1 interaction in further detail by
performing a GDI assay, and we determined that Phg2-RA
binds to Rap1 with a dissociation constant of 30 M.
Although this affinity is relatively low, other parts of the
Phg2 protein may stabilize the interaction and increase the
affinity as observed in other Rap-RA interactions (38). Phg2
also contains a serine/threonine-specific kinase and proline-
rich repeats and plays an important role in substrate adhe-
sion, cellular adhesion, phagocytosis, actin cytoskeleton
reorganization, and motility (19). Recently Bla´nc et al. (46)
identified a new inositol 4,5-diphosphate binding domain
that is essential and sufficient for the membrane localization
of Phg2 and that this membrane localization is necessary for
proper functioning of the protein. This inositol 4,5-diphos-
phate binding domain comprises amino acids 81–193, distal
from the RA and kinase domains. Because Phg2 is mem-
brane-bound, binding of Rap1 to Phg2 is likely to alloster-
ically activate Phg2. Such a mechanism of activation has
been described for Rho family protein-dependent kinases
such as Pak or Rho-associated kinase (ROCK) (47) but, pre-
sumably, differs from Ras-regulated kinases such as Raf-1
and B-RAF. Binding of Ras to the Ras binding domain of Raf
FIGURE 7. Model of the GbpD-activated Rap1 pathway in Dictyostelium
regulating adhesion and cell morphology. Dictyostelium Rap1 switches
between an active GTP-bound and inactive GDP-bound state. GbpD is one of
the GEFs that catalyzes the exchange of GDP for GTP, thereby activating the
Rap1 protein. For the inactivation of Rap1-GTP, GAPs (not identified yet) are
necessary to accelerate the intrinsic slow GTP hydrolysis. Active Rap is
involved in regulating adhesion and cell polarity. Phg2, a serine/threonine-
specific kinase, directly interacts with active Rap1 via its RA domain and is
necessary for Rap1- regulated adhesionbut is not essential forGbpD-induced
changes of cell morphology. cNB, cyclic nucleotide binding domain.
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results in recruitment of the protein to the membrane rather
than in its direct activation (48).
GbpDOE mutants are severely impaired in chemotaxis.
Previously we proposed that the chemotaxis defect is prob-
ably due to the formation of many substrate-attached pseu-
dopodia that leads to an increased adhesion and a concomi-
tant decrease in polarity (17). The data from this report allow
for a refinement of this model (Fig. 7).We identified GbpD as
one of the GEFs that catalyze the exchange of GDP for GTP,
thereby activating Rap1. For the inactivation, not yet identi-
fied GAPs are necessary to accelerate the intrinsic slow GTP
hydrolysis by many orders of magnitude. Active Rap is
involved in regulating adhesion and cell polarity. Phg2, a
serine/threonine-specific kinase, directly interacts with
active Rap1 via its RA domain and is necessary for Rap1-
regulated adhesion. However, the observation that phg2/
GbpDOE cells exhibit defects in cell polarity and, thus, che-
motaxis indicates that there must be additional Rap1
effectors in Dictyostelium. The Rap1 effector involved in cell
polarity might be identified using screens for suppression of
the strong effect of overexpression of GbpD on cell morphol-
ogy either by mutation or pharmacological inhibition of the
Rap target.
In summary, GbpD is a Dictyostelium Rap-GEF involved in
adhesion and cell polarity. Phg2, a serine/threonine-specific
kinase, directly interacts with Rap1 via its RA domain. Phg2 is
necessary for the Rap1-regulated adhesion but not for Rap1-
regulated cell polarity.
Acknowledgment—The phg2-, talinA-, and myosin VII-null cell
strains were kindly provided by Pierre Cosson.
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